[Form 4] Affirm Holdings, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Michael Linford, Chief Operating Officer of Affirm Holdings (AFRM) reported transactions on 08/18/2025 showing he exercised 10,800 stock options at an exercise price of $5.39 per share and immediately sold 10,800 Class A shares at $80.00 per share under a Rule 10b5-1 trading plan adopted on February 14, 2025. After these transactions he beneficially owned 109,840 Class A shares directly and held options/rights such that his total beneficial position related to Class A common stock was 718,070 shares (including unvested option shares). The Form 4 was signed by attorney-in-fact on 08/20/2025.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider exercised options then sold the same 10,800 shares under a pre-established 10b5-1 plan; transaction appears routine and compliant.
The reporting shows an option exercise at $5.39 followed by an immediate sale at $80.00 executed under a 10b5-1 plan adopted Feb 14, 2025. This sequence realizes substantial pre-tax gains per share and reduces the reporting person's direct share count from 120,640 to 109,840. The filing discloses remaining derivative exposure totaling 718,070 shares when including options/rights. For investors, this is a liquidity event by an officer but is documented as an approved, rule-compliant plan rather than an opportunistic sale disclosed outside plan parameters.
TL;DR: The trade follows governance best practices by using a documented 10b5-1 plan; disclosure is clear on vesting and plan adoption.
The Form 4 explicitly states the sale was effected pursuant to a Rule 10b5-1 trading plan and provides the plan adoption date. The filing also includes the option vesting schedule (vesting commencement 08/27/2018 and monthly vesting thereafter) which clarifies how exercised shares remain subject to service-based vesting. Documentation and prompt Form 4 reporting align with standard insider-transparency expectations.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 10,800 | $0.00 | -- |
| Exercise | Class A Common Stock | 10,800 | $5.39 | $58K |
| Sale | Class A Common Stock | 10,800 | $80.00 | $864K |
Footnotes (1)
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2025. Stock options vest with respect to 1/4 of the shares of the Issuer's Class A common stock underlying the stock option on the one-year anniversary of August 27, 2018, the vesting commencement date, and the remaining 3/4 of the shares underlying the option vest in equal monthly installments over the subsequent three years, in each case subject to continued service with the Issuer. The Reporting Person can elect to exercise the stock options at any time, provided that the shares acquired upon exercise remain subject to the applicable vesting schedule.